Platelet granule growth factor release

Platelet granule growth factor release refers to the physiological process whereby activated platelets secrete a range of bioactive proteins and growth factors from their granules, particularly α-granules, into the extracellular environment. These factors — most notably platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β1), vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF-1), and various chemokines and cytokines — mediate crucial steps in tissue repair, angiogenesis, inflammation, and immune regulation[1][2][3]. The release mechanism relies on vesicle-plasma membrane fusion, mediated by SNARE proteins (e.g., VAMPs, syntaxins, SNAP-23) and regulatory proteins like Munc18c[2]. This process is not itself a druggable target, but released growth factors may be targeted individually through their respective receptors (e.g., PDGFRα, PDGFRβ, VEGFR)[3]. Dysfunctional platelet granule release is implicated in disorders of hemostasis, inflammation, and cardiovascular diseases. In summary, "platelet granule growth factor release" represents a fundamental biological process rather than a specific, canonical molecular drug target.

Other names

Release of platelet-derived growth factorsPlatelet degranulationPlatelet α-granule secretion